Tenderwize
Back to tender search

Open House Originale Agreement for Vericiguat

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 29, 2027 · 406 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-24 - Vericiguat

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

Offers/contracts cannot be submitted via the portal; the notice says portal submission is technically not possible and...

Participation is limited to pharmaceutical undertakings with the required AMG status, seat location, authorisation, and...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Sep 2027
  • Supply/rebate agreement for pharmaceutical products, specifically the active substance Vericiguat.
  • Open House arrangement with uniform contractual conditions for all eligible participants.
Show full summary

This is a German Open House supply arrangement for Vericiguat (CPV 33600000 Pharmaceutical products) led by Techniker Krankenkasse, with hkk and HEK listed as participating buyers. It is not a classic competitive award procedure: all eligible pharmaceutical companies meeting the stated conditions may join during the contract period, with no exclusivity and no individual negotiations. The contract term is up to 24 months from 01.10.2025 to 30.09.2027, with automatic earlier end if patent/market exclusivity expires. No contract value is stated. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the procurement documents are available electronically but were not analyzed in extracted text beyond the notice.

Risks

Offers/contracts cannot be submitted via the portal; the notice says portal submission is technically not possible and...

Participation is limited to pharmaceutical undertakings with the required AMG status, seat location, authorisation, and...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of Section 4(18) AMG for the relevant medicinal product.
  • Applicant must have its seat in Germany, another EU Member State, or an EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicinal product and/or otherwise be entitled to place it on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House Originale Agreement for Vericiguat

Open House supply arrangement for the active substance Vericiguat. The notice states that all suitable pharmaceutical companies may conclude a rebate agreement under Section 130c(1) SGB V. No exclusivity, no individual negotiations, and uniform conditions apply. The lot is nationwide in Germany.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Sep 2025 - Sep 2027

Category

Pharmaceutical products

Deadline

Deadline Sep 29, 2027

Procurement Details

Publication date
18 Aug 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
540042-2025

Documents (1)

Similar tenders